TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10768304

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 743

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 743
Study: 8730079

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 10 Hz, cosine phase, modulation index varied
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 10 Hz, cosine phase, fixed modulation index m at 0.5, roved background harmonic levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 10 Hz, random phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 2 Hz, cosine phase, all formants modulated in phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 2 Hz, random phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 2 Hz, randomizing level of each background harmonic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amplitude modulation (AM) at or close to 2 Hz, differing phase across formants
Number of subjects: 0
Study: 1804649

Group type: EXPERIMENTAL
Intervention: SR 33557 (100 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: SR 33557 (300 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6342980

Group type: EXPERIMENTAL
Intervention: Zinc pyrithione shampoo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Shampoo base
Number of subjects: 40
Study: 31693879

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (SGLT2 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29202563

Group type: EXPERIMENTAL
Intervention: Nebulized hyaluronic acid (HA) via Spray-sol, twice a day for 10 days (T1)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Physiological saline nebulized via Spray-sol, twice a day for 10 days (T2)
Number of subjects: 25
Study: 25370359

Group type: EXPERIMENTAL
Intervention: Dietary support (D)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Knee-exercise program (E)
Number of subjects: 192

Group type: COMPARATOR
Intervention: No attention (C)
Number of subjects: 192
Study: 24326281

Group type: EXPERIMENTAL
Intervention: Decision aid intervention
Number of subjects: 515

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 515
Study: 23559924

Group type: EXPERIMENTAL
Intervention: OptiBond FL (Kerr, USA)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (Kuraray, Japan) with enamel etching
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ethanol wet bonding technique with part of adhesive of OptiBond FL
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 19668121

Group type: EXPERIMENTAL
Intervention: quetiapine XR 50 mg/day
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: quetiapine XR 150 mg/day
Number of subjects: 723

Group type: EXPERIMENTAL
Intervention: quetiapine XR 300 mg/day
Number of subjects: 723

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 723
Study: 17602036

Group type: EXPERIMENTAL
Intervention: Milrinone (bolus and infusion before cardiopulmonary bypass until skin closure)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15369795

Group type: EXPERIMENTAL
Intervention: HPV 16-positive women
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: HPV 16-positive women with CIN 3 or invasive cancer
Number of subjects: 197
Study: 12365907

Group type: COMPARATOR
Intervention: Standard AcrySof MA30 intraocular lens (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MA30 intraocular lens with a textured optic edge (group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 9833595

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg after food
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zolmitriptan (all doses)
Number of subjects: 32
Study: 8566267

Group type: EXPERIMENTAL
Intervention: Pulsatile administration of hMG
Number of subjects: 88

Group type: COMPARATOR
Intervention: Bolus administration of hMG
Number of subjects: 88
Study: 2081896

Group type: EXPERIMENTAL
Intervention: Fluoxetine (60 mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Amitriptyline (150 mg)
Number of subjects: 34
Study: 7428356

Group type: EXPERIMENTAL
Intervention: Natural estrogen product (4mg estradiol + 2mg estriol)
Number of subjects: 925

Group type: COMPARATOR
Intervention: Ethinyl estradiol product (50 microgram ethinyl estradiol)
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Natural estrogen product
Number of subjects: 925

Group type: COMPARATOR
Intervention: Ethinyl estradiol product
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Both products
Number of subjects: 925
Study: 30953792

Group type: EXPERIMENTAL
Intervention: NTproBNP measured at baseline, 48-72 hours, and 30 days
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Relative changes in NTproBNP
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Absolute and relative changes in NTproBNP from baseline to 48-72 hours and to 30 days
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Multivariable models with relative and absolute change in NTproBNP
Number of subjects: 795
Study: 28372555

Group type: EXPERIMENTAL
Intervention: Staff educational programme delivered by the team of researchers
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 28
Study: 26413500

Group type: EXPERIMENTAL
Intervention: 600 mg DHA supplementation
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 871

Group type: COMPARATOR
Intervention: Combined DHA supplementation (300 and 600 mg/day)
Number of subjects: 871

Group type: EXPERIMENTAL
Intervention: RBC DHA increase
Number of subjects: 871

Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 871
Study: 25168665

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/d + Pregabalin 300 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination/high-dose therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 0
Study: 22862951

Group type: EXPERIMENTAL
Intervention: Pringle maneuver
Number of subjects: 498

Group type: COMPARATOR
Intervention: Non-Pringle group
Number of subjects: 498
Study: 20704667

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with parameters: wavelength 905 nm, frequency 5,000 Hz, power density of 12 mW/cm², dose of 2 J/cm², treatment time 120 seconds, total dose 12 J/cm²
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo procedure (inactive laser)
Number of subjects: 60
Study: 17654276

Group type: EXPERIMENTAL
Intervention: Semantic intrusions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Onset intrusions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rhyme intrusions
Number of subjects: 0
Study: 16295700

Group type: EXPERIMENTAL
Intervention: High fidelity e-mail-based walking program
Number of subjects: 61

Group type: COMPARATOR
Intervention: Low fidelity e-mail-based walking program
Number of subjects: 61
Study: 11864673

Group type: EXPERIMENTAL
Intervention: Intrapartum epidural analgesia
Number of subjects: 116
Study: 10651664

Group type: EXPERIMENTAL
Intervention: OAC (omeprazole 20 mg b.d., amoxycillin 1 g b.d., clarithromycin 500 mg b.d.)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: OAM (omeprazole 20 mg b.d., amoxycillin 1 g b.d., metronidazole 400 mg b.d.)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: OMC (omeprazole 20 mg b.d., metronidazole 400 mg b.d., clarithromycin 500 mg b.d.)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Pre-treatment metronidazole resistance
Number of subjects: 246
Study: 8554362

Group type: EXPERIMENTAL
Intervention: Tape recorded summary
Number of subjects: 113
Study: 2403655

Group type: EXPERIMENTAL
Intervention: Cefonicid (1 g intravenously) administered approximately half an hour before surgery
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Cefonicid
Number of subjects: 1218
Study: 331920

Group type: EXPERIMENTAL
Intervention: Betahistine 24 mg daily
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 31944221

Group type: EXPERIMENTAL
Intervention: Dasatinib (80 mg/m2 daily)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Imatinib (300 mg/m2 daily)
Number of subjects: 189
Study: 31854606

Group type: EXPERIMENTAL
Intervention: Land use types within a 500 m buffer zone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Land use types within a 1 km buffer zone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Built‐up land
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Farmland
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rivers within a 200 m buffer zone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Percentage of lake area
Number of subjects: 30
Study: 27965045

Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Best Medical Treatment (BMT)
Number of subjects: 36
Study: 25321162

Group type: EXPERIMENTAL
Intervention: 2.5% mannitol
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 2.5% mannitol + 10 mg scopolamine butylbromide
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 2.5% mannitol + 20 mg scopolamine butylbromide
Number of subjects: 124

Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 124
Study: 23837833

Group type: EXPERIMENTAL
Intervention: Improvement strategy tailored to barriers and facilitators
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard strategy of audit and feedback
Number of subjects: 19
Study: 22057498

Group type: EXPERIMENTAL
Intervention: HPPH-PDT with 3 mg/m2 HPPH plus 175 J/cm light
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HPPH-PDT with 4 mg/m2 HPPH plus 150 J/cm light
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HPPH-PDT with 3 mg/m2 HPPH (light dose of 150 J/cm at 48 hours)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HPPH-PDT with 4 mg/m2 HPPH (light dose at 24 hours)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HPPH-PDT
Number of subjects: 36
Study: 18958483

Group type: EXPERIMENTAL
Intervention: Amniotomy and immediate oxytocin infusion
Number of subjects: 123

Group type: COMPARATOR
Intervention: Amniotomy and delayed oxytocin infusion
Number of subjects: 123
Study: 16775166

Group type: EXPERIMENTAL
Intervention: History of injecting drug use
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Hepatitis C virus infection
Number of subjects: 694

Group type: COMPARATOR
Intervention: Sexually transmitted infections, sexual behavior, blood transfusions, influenza, acne, occupational or domestic exposure to zoonotic infections
Number of subjects: 694
Study: 15565373

Group type: EXPERIMENTAL
Intervention: Glibenclamide + Metformin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Gliclazide
Number of subjects: 118

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 118
Study: 12964326

Group type: EXPERIMENTAL
Intervention: K-Four high compression bandage system
Number of subjects: 50

Group type: COMPARATOR
Intervention: Earlier evaluated bandages (including the original Charing Cross system)
Number of subjects: 50
Study: 9140679

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Celiprolol 200 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8794554

Group type: EXPERIMENTAL
Intervention: Visual suppression tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Verbal suppression tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Single complexity tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Double complexity tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Mixed complexity tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Easy difficulty tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Optimal difficulty tasks
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Difficult difficulty tasks
Number of subjects: 608
Study: 2530027

Group type: EXPERIMENTAL
Intervention: 3% BPAA gel
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 1101820

Group type: EXPERIMENTAL
Intervention: Topical polyinosinic acid-polycytidylic acid [poly(I:C)]
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 24
Study: 31234806

Group type: EXPERIMENTAL
Intervention: FSMS-RUTF
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: MSMS-RUTF
Number of subjects: 389

Group type: COMPARATOR
Intervention: PM-RUTF
Number of subjects: 389
Study: 28806436

Group type: EXPERIMENTAL
Intervention: On the Move group exercise program
Number of subjects: 298

Group type: COMPARATOR
Intervention: Usual care exercise program
Number of subjects: 298
Study: 25914263

Group type: EXPERIMENTAL
Intervention: Reduced toxicant prototype (RTP) cigarette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cigarette
Number of subjects: 0
Study: 23480992

Group type: EXPERIMENTAL
Intervention: Maternal hemoglobin
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Maternal total protein
Number of subjects: 168
Study: 21656724

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Operation
Number of subjects: 160
Study: 19237443

Group type: EXPERIMENTAL
Intervention: Substantial alcohol exposure in movies and commercials
Number of subjects: 2

Group type: COMPARATOR
Intervention: No alcohol portrayal
Number of subjects: 2
Study: 17078436

Group type: EXPERIMENTAL
Intervention: Point application of medicated cakes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketotifen (control group)
Number of subjects: 60
Study: 15198873

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin at a target dose of 14 microg/kg/h
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 17
Study: 11389251

Group type: EXPERIMENTAL
Intervention: SIPPV plus VG
Number of subjects: 40

Group type: COMPARATOR
Intervention: SIPPV
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SIMV plus VG
Number of subjects: 40

Group type: COMPARATOR
Intervention: SIMV
Number of subjects: 40
Study: 8988940

Group type: EXPERIMENTAL
Intervention: Total fat intake (38.4% of energy)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Saturated fatty acids intake (14.2%)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Dietary cholesterol intake (492 mg/d)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Special diet adherence
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Fat intake
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Dietary patterns
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Intake of total energy and dietary fats
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Dairy product consumption
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Eggs, sugars, and sweets consumption
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Cereal foods intake
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Dietary habits based on education level
Number of subjects: 1000
Study: 8236129

Group type: EXPERIMENTAL
Intervention: Avoidance of fatty foods in the month before interview
Number of subjects: 4246

Group type: EXPERIMENTAL
Intervention: Increased consumption of fatty foods
Number of subjects: 4246

Group type: EXPERIMENTAL
Intervention: Usual amount of fatty food consumption
Number of subjects: 4246

Group type: EXPERIMENTAL
Intervention: Dietary fat reduction
Number of subjects: 4246

Group type: EXPERIMENTAL
Intervention: Low fat diet
Number of subjects: 4246
Study: 2904474

Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: betaxolol 0.5%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: carteolol 2%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: pilocarpine 2%
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: acetazolamide 750 mg per os
Number of subjects: 50
Study: 29650204

Group type: EXPERIMENTAL
Intervention: Pacifier and swaddling
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no pacifier and swaddling)
Number of subjects: 30
Study: 28814387

Group type: EXPERIMENTAL
Intervention: Aprepitant (125 mg on day 1, followed by 80 mg on days 2-5)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 25998093

Group type: EXPERIMENTAL
Intervention: Memantine (5 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23073511

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 70

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 70
Study: 21227483

Group type: EXPERIMENTAL
Intervention: Piracetam 4.8 g daily for 6 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo treatment for 6 months
Number of subjects: 30
Study: 18494791

Group type: EXPERIMENTAL
Intervention: 50 mg/day TPM
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 200 mg/day TPM
Number of subjects: 77
Study: 16813180

Group type: EXPERIMENTAL
Intervention: Consciousness‐restoring resuscitation acupuncture (treatment group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chinese medicine (control group)
Number of subjects: 60
Study: 12673081

Group type: EXPERIMENTAL
Intervention: CIC 1% cream
Number of subjects: 303

Group type: COMPARATOR
Intervention: KC 2% foaming gel
Number of subjects: 303
Study: 10761807

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 769

Group type: COMPARATOR
Intervention: No CABG or diabetes
Number of subjects: 769

Group type: EXPERIMENTAL
Intervention: Clinical and demographic factors
Number of subjects: 769
Study: 8970279

Group type: EXPERIMENTAL
Intervention: Resistance training (14 weeks, 3 times per week using elastic bands)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Resistance training group vs Control group
Number of subjects: 42
Study: 1599264

Group type: EXPERIMENTAL
Intervention: 17 mg/mL cyclosporine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 10 mg/mL cyclosporine
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: 2.5 mg/mL cyclosporine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 31
Study: 6202408

Group type: EXPERIMENTAL
Intervention: Continuous infusion of bleomycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intermittent bolus injection of bleomycin
Number of subjects: 0
Study: 30717805

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (transfusion of a single RBC unit when Hb ≤ 9 g/dl with a target range for post-transfusion Hb level of 9-10.5 g/dl)
Number of subjects: 2470

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (transfusion of a single RBC unit when Hb ≤ 7.5 g/dl with a target range for post-transfusion Hb level of 7.5-9 g/dl)
Number of subjects: 2470

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy
Number of subjects: 2470

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy
Number of subjects: 2470
Study: 30397236

Group type: EXPERIMENTAL
Intervention: Endorectal cooling balloon (ECB) for regional hypothermia
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control group (no hypothermia)
Number of subjects: 199
Study: 26898919

Group type: EXPERIMENTAL
Intervention: Carotid compression during arterial cannulation and aortic declamping
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carotid compression during arterial cannulation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carotid compression during aortic declamping
Number of subjects: 40

Group type: COMPARATOR
Intervention: No carotid compression (control group)
Number of subjects: 40
Study: 25265986

Group type: EXPERIMENTAL
Intervention: 3% Rumex occidentalis cream
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4% Hydroquinone cream
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 45
Study: 23146648

Group type: EXPERIMENTAL
Intervention: Self-Adjusting File (SAF; ReDent Nova)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Typhoon (Typhoon rotary files with Controlled Memory Wire; DS Dental)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Vortex (ProFile Vortex rotary files with M-Wire NiTi; Dentsply Tulsa Dental Specialties)
Number of subjects: 72
Study: 20380479

Group type: EXPERIMENTAL
Intervention: Ketoprofen syrup 0.5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen suspension 5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paracetamol suspension 15 mg/kg
Number of subjects: 0
Study: 18852422

Group type: EXPERIMENTAL
Intervention: Visual impairment
Number of subjects: 14037

Group type: EXPERIMENTAL
Intervention: Visual impairment (adjusted for confounding factors)
Number of subjects: 14037
Study: 16115978

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (Mg) 2.48 mmol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ketamine 0.2 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 100
Study: 12353197

Group type: EXPERIMENTAL
Intervention: Valacyclovir 250 mg (9.4‐13.3 mg/kg) twice daily
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg (13.9‐27.0 mg/kg) twice daily
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg (13.2‐21.7 mg/kg) 3 times a day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intravenous acyclovir (historical data)
Number of subjects: 28
Study: 10079655

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care education program
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Focus group method
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Small group learning modules
Number of subjects: 2